US Stock MarketDetailed Quotes

RGEN Repligen

Watchlist
  • 143.630
  • -1.120-0.77%
Close Apr 28 16:00 ET
  • 142.110
  • -1.520-1.06%
Pre 05:56 ET
8.07BMarket Cap-312.24P/E (TTM)

About Repligen Company

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Company Profile

SymbolRGEN
Company NameRepligen
Listing DateMay 6, 1986
Founded1981
CEOMr. Olivier Loeillot
MarketNASDAQ
Employees1778
Fiscal Year Ends12-31
Address41 Seyon Street,Building 1, Suite 100
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-250-0111

Company Executives

  • Name
  • Position
  • Salary
  • Olivier Loeillot
  • Director, President and Chief Executive Officer
  • 7.18M
  • Jason K. Garland
  • Chief Financial Officer and Principal Accounting Officer
  • 2.11M
  • James R. Bylund
  • Chief Operating Officer
  • 4.17M
  • Ralf Kuriyel, PhD
  • Senior Vice President, Research and Development
  • 1.99M
  • Tony J. Hunt
  • Executive Chairman of the Board
  • 20.30M
  • Margaret A. Pax
  • Independent Director
  • 540.49K
  • Karen A. Dawes, M.A.
  • Lead Independent Director
  • 428.40K
  • Carrie Eglinton Manner
  • Independent Director
  • 306.65K
  • Nicolas M. Barthelemy
  • Independent Director
  • 324.98K
  • Glenn P. Muir
  • Independent Director
  • 338.32K
  • Dr. Rohin Mhatre, PhD
  • Independent Director
  • 306.65K
  • Dr. Martin D. Madaus,PhD
  • Independent Director
  • 316.98K
  • Dr. Konstantin Konstantinov, PhD
  • Independent Director
  • 301.65K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More